PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry. More Details
Flawless balance sheet and overvalued.
Share Price & News
How has PD-Rx Pharmaceuticals's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: PDRX has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: PDRX underperformed the US Healthcare industry which returned 17.2% over the past year.
Return vs Market: PDRX underperformed the US Market which returned 10.9% over the past year.
Price Volatility Vs. Market
How volatile is PD-Rx Pharmaceuticals's share price compared to the market and industry in the last 5 years?
Simply Wall St News
Is PD-Rx Pharmaceuticals undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate PDRX's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate PDRX's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: PDRX is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.
PE vs Market: PDRX is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate PDRX's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: PDRX is good value based on its PB Ratio (0.7x) compared to the US Healthcare industry average (2.6x).
How is PD-Rx Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as PD-Rx Pharmaceuticals has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine PD-Rx Pharmaceuticals's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on theOTC Markets Website. If you are looking for more of a qualitative research into the company, you can access PD-Rx Pharmaceuticals's filings and announcementshere.
- Explore growth companies in the Healthcare industry.
How has PD-Rx Pharmaceuticals performed over the past 5 years?
Last years earnings growth
Earnings and Revenue History
Quality Earnings: PDRX is currently unprofitable.
Growing Profit Margin: PDRX is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if PDRX's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare PDRX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PDRX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (31.1%).
Return on Equity
High ROE: PDRX has a negative Return on Equity (-0.18%), as it is currently unprofitable.
How is PD-Rx Pharmaceuticals's financial position?
Financial Position Analysis
Short Term Liabilities: PDRX's short term assets ($7.6M) exceed its short term liabilities ($1.6M).
Long Term Liabilities: PDRX has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: PDRX is debt free.
Reducing Debt: PDRX has not had any debt for past 5 years.
Debt Coverage: PDRX has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: PDRX has no debt, therefore coverage of interest payments is not a concern.
What is PD-Rx Pharmaceuticals's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate PDRX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PDRX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if PDRX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PDRX's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of PDRX's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Robert Holsey (67 yo)
Dr. Robert D. Holsey D.O., R.Ph. has been a Director of Pd-rx Pharmaceuticals Inc. since 1986 and serves as President, Chief Executive Officer and Chairman of the Board and a practicing physician. Dr. Hols ...
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
PD-Rx Pharmaceuticals, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: PD-Rx Pharmaceuticals, Inc.
- Ticker: PDRX
- Exchange: OTCPK
- Founded: 1986
- Industry: Health Care Distributors
- Sector: Healthcare
- Market Cap: US$5.145m
- Shares outstanding: 1.72m
- Website: https://www.pdrx.com
- PD-Rx Pharmaceuticals, Inc.
- 727 North Ann Arbor
- Oklahoma City
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|PDRX||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Jan 1992|
PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry. It offers branded and generic pharmaceuticals, unit dose products ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/26 06:04|
|End of Day Share Price||2020/09/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.